{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:06:54Z","timestamp":1769184414730,"version":"3.49.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,15]]},"DOI":"10.1097\/tp.0b013e318255f864","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T00:14:33Z","timestamp":1342138473000},"page":"281-286","source":"Crossref","is-referenced-by-count":36,"title":["A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease After Lung Transplantation"],"prefix":"10.1097","volume":"94","author":[{"given":"Sophia","family":"Koo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Kubiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas C.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Dietzek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Boukedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip C.","family":"Camp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey R.","family":"Baden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne L.","family":"Fuhlbrigge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco M.","family":"Marty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"suppl 4","key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1111\/j.1600-6143.2009.02910.x","article-title":"Invasive aspergillosis in solid organ transplant recipients.","volume":"9","author":"Singh","year":"2009","journal-title":"Am J Transplant"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":". Voriconazole prophylaxis in lung transplant recipients.","volume":"6","author":"Husain","year":"2006","journal-title":"Am J Transplant"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/00007890-199603270-00013","article-title":". Aspergillus infection in single and double lung transplant recipients.","volume":"61","author":"Westney","year":"1996","journal-title":"Transplantation"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/JCM.01183-10","article-title":". The (1,3)beta-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.","volume":"48","author":"Alexander","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.healun.2003.09.028","article-title":". A survey of anti-fungal management in lung transplantation.","volume":"23","author":"Dummer","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-6143.2010.03375.x","article-title":". Antifungal prophylaxis in lung transplantationA world-wide survey.","volume":"11","author":"Neoh","year":"2011","journal-title":"Am J Transplant"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/j.1600-6143.2009.02734.x","article-title":". Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.","volume":"9","author":"Cadena","year":"2009","journal-title":"Am J Transplant"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1399-3062.2002.t01-2-02002.x","article-title":". The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.","volume":"4","author":"Minari","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"E163","DOI":"10.1111\/j.1399-0012.2010.01373.x","article-title":". Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.","volume":"25","author":"Kramer","year":"2010","journal-title":"Clin Transplant"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1128\/AAC.00504-10","article-title":". Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients.","volume":"54","author":"Han","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-12-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":". Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":". Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of CancerInvasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTCMSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1399-0012.2009.01076.x","article-title":". The impact of invasive fungal diseases on survival after lung transplantation.","volume":"24","author":"Arthurs","year":"2010","journal-title":"Clin Transplant"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-3062.2009.00364.x","article-title":". Trends in invasive disease due to Candida species following heart and lung transplantation.","volume":"11","author":"Schaenman","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":". Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.2010.885","article-title":". Survival differences following lung transplantation among US transplant centers.","volume":"304","author":"Thabut","year":"2010","journal-title":"JAMA"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/647942","article-title":". Diagnostic performance of the (1-3)-beta-D-glucan assay for invasive fungal disease.","volume":"49","author":"Koo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R19-12-20210129","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.healun.2010.05.022","article-title":". Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.","volume":"29","author":"Vadnerkar","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/cid\/ciq188","article-title":". Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.","volume":"52","author":"Wermers","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R21-12-20210129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-152-12-201006150-00003","article-title":". Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial.","volume":"152","author":"Palmer","year":"2010","journal-title":"Ann Intern Med"},{"key":"R22-12-20210129","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":". Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e318255f864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:28:00Z","timestamp":1620977280000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201208150-00012"}},"subtitle":["A Sequential Cohort Analysis"],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318255f864","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,15]]}}}